G
Gradient Denervation Technologies
Biotech & Life Sciences · Paris, France · Founded 2019
Developing a novel endovascular, catheter-based technology to treat pulmonary hypertension MoreLess
Gradient Denervation Technologies is a Paris-based medical device startup that focuses on the development of a unique, minimally invasive ultrasound-based catheter. This device is designed to treat heart failure patients who also suffer from pulmonary hypertension, a condition characterized by high blood pressure in the arteries of the lungs. The company's innovative therapeutic approach aims to improve cardiovascular health.
The company's target market includes patients suffering from Group 2 pulmonary hypertension, which is heart failure accompanied by high pulmonary vascular resistance. The company's business model revolves around the development, clinical testing, and eventual commercialization of its novel catheter-based system.
Gradient Denervation Technologies recently closed a €14m Series A funding round led by Sabadell Asabys, with participation from Thuja Capital and founding investor Sofinnova Partners. These funds will be used to advance the clinical development of the company's device.
The company has already enrolled its first patient in a first-in-human clinical study, marking a significant milestone in its journey. The company is led by CEO Martin Grasse, a veteran with over 15 years in the medical device industry.
In summary, Gradient Denervation Technologies is a promising startup in the medical device sector, with a focus on improving the lives of heart failure patients with associated pulmonary hypertension. Its innovative, minimally invasive device has the potential to revolutionize treatment in this area.
Keywords: Medical Device, Heart Failure, Pulmonary Hypertension, Minimally Invasive, Catheter, Cardiovascular Health, Clinical Development, Series A Funding, First-in-Human Study, Paris-based Startup.
Company overview
Gradient Denervation Technologies company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2019
- Headquarters
- Paris, France
- Employees
- 18
- Open positions
- 1
- Dealroom signal
- 78.0
Valuation & funding
Gradient Denervation Technologies funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Sep 2023 | $15M | $62M | Sofinnova Partners · Thuja Capital · Asabys Partners | ↗ |
| SUPPORT PROGRAM✓Other financing | Jun 2022 | $0 | — | MedTech Innovator | ↗ |
| SUPPORT PROGRAM✓Other financing | Jan 2022 | $0 | — | EIT Health | — |
| SUPPORT PROGRAM✓Other financing | Dec 2020 | $11K | — | EIT Health | — |
| SEED✓Equity / VC | Sep 2020 | $3.9M | $15M | Sofinnova Partners | — |
| SEEDEquity / VC | Feb 2020 | MD Start Accelerator | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $18K | 0% | 18 |
| 2025 | $18K | 0% | 15 |
| 2024 | $18K | 0% | 13 |
| 2023 | $18K | +60% | 9 |
| 2022 | $11K | 0% | 7 |
| 2021 | $11K | -90.9% | 4 |
| 2020 | $121K | — | 4 |
Growth signals
Gradient Denervation Technologies website traffic
Latest recorded traffic for Gradient Denervation Technologies is 540 monthly website visits, down 25% over the last three months. Gradient Denervation Technologies's team grew 20% over the past year.
Hiring
Open positions at Gradient Denervation Technologies
Current openings linked to this company in Dealroom.
Comparisons
Gradient Denervation Technologies compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Gradient Denervation Technologies's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Gradient Denervation Technologies has talent and traffic
team presence
In the news
Latest news about Gradient Denervation Technologies
Recent press, funding announcements, and product moves mentioning Gradient Denervation Technologies — open to read from the original sources.
Market sentiment
What the market is saying about Gradient Denervation Technologies
An AI-synthesized read of the highest-engagement posts about Gradient Denervation Technologies on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Gradient Denervation Technologies’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.